Novartis Investigative Site

Weiden in Der Oberpfalz, Bavaria 92637

1 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease and Lipoprotein(a), Early Breast Cancer

Studies at this site

• An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) — Recruiting now
• Phase IIIb Study of Ribociclib + ET in Early Breast Cancer — Recruiting now
• Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD — Running, not enrolling